Live feed
Filing
SC 13D/A
SC 13D/A0000903423-19-000002·Sio Gene Therapies Inc.
Schedule 13D ownership disclosure
AXOVANT SCIENCES LTD
Security class unavailable · CUSIP: G0750W104
Event date: 2019-01-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 99,285,714
- Percent of class
- 65.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-19-000002
- Form type
- SC 13D/A
- Filer
- Sio Gene Therapies Inc.
- CIK
- CIK 1636050
- Filed
- Jan 03, 2019
- Reporting period
- Jan 01, 2019
- Description
- Schedule 13D beneficial ownership